News & Updates

An app-based program for lifestyle change effectively helps users achieve significant weight loss and improve glycaemia in adults with prediabetes, according to a recent Singapore study. Such interventions could potentially be used alongside current standard approaches for preventing diabetes.

While gestational diabetes is known to be associated with an increased risk of cardiovascular (CV) disease later in life, the extent of CV risk has only come to light in a study presented at the 2022 SMFM Annual Meeting.

Hypoglycaemia appears to be common among infants who receive therapeutic hypothermia for hypoxic-ischaemic encephalopathy, a new study reveals. Moreover, these infants also tend to show higher degrees of brain injury and lower cognitive function at school age.

In the real-world treatment of Asian patients with type 2 diabetes mellitus (T2DM), the blood glucose-lowering benefit following oral antidiabetic drug (OAD) dose escalation is lesser than what has been reported in clinical trials, according to a study from Singapore.

In individuals with progressive locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC), the VEGFR-2* inhibitor apatinib demonstrated significant clinical benefits in terms of progression-free survival (PFS) and overall survival (OS), with a manageable safety profile, findings from the phase III REALITY trial suggest.

Regular monitoring of expecting mothers can help reduce maternal death rates from eclampsia in the country, say experts.

Targeted next-generation sequencing (NGS) appears to be useful for pinpointing causal variants in patients with suspected monogenic diabetes (MD), broadening the spectrum of new pathogenic variants and updating knowledge of the clinical features of patients with various forms of MD, according to a recent study.